News
(Reuters) -Infant hospitalizations due to respiratory syncytial virus (RSV) infections in the United States dropped as much ...
Michael Hakes, senior portfolio manager at Murray Wealth Group, discusses his past stock picks and how they're doing in the ...
In the POTOMAC study, one year of treatment with Imfinzi (durvalumab) plus standard-of-care BCG induction and maintenance ...
Calquence (acalabrutinib) plus bendamustine and rituximab reduced risk for disease progression or death by 27% compared with ...
Imfinzi plus BCG induction and maintenance therapy showed a statistically and clinically meaningful improvement in DFS for ...
AstraZeneca aims to widen the pool of bladder cancer patients who can be treated with its PD-L1 inhibitor Imfinzi after the ...
8h
Zacks Investment Research on MSNHow Much Upside is Left in Astrazeneca (AZN)? Wall Street Analysts Think 27.89%Astrazeneca (AZN) closed the last trading session at $67.30, gaining 3.8% over the past four weeks, but there could be plenty ...
House Republicans are considering nixing a Medicaid drug-pricing plan floated by President Trump and fiercely opposed by ...
U.K. trade deal came in an email from the White House on pharmaceuticals. The upshot -- once the U.S. comes up with tariffs on pharmaceuticals, the U.K. drug industry will quickly get lowered rates.
US President Donald Trump and British Prime Minister Keir Starmer on Thursday announced a limited bilateral trade agreement that leaves in place Trump's 10% tariffs on British exports, modestly ...
Enhertu delivered a phase 3 trial win in early-stage breast cancer. Takeda spotlighted three late-stage readouts as a ...
Far fewer babies had severe cases of the respiratory illness RSV, in a winter in which a new monoclonal and vaccine became ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results